126 related articles for article (PubMed ID: 26038202)
21. Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.
Bertherat J; Groussin L; Bertagna X
Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):632-41. PubMed ID: 17082810
[TBL] [Abstract][Full Text] [Related]
22. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
[TBL] [Abstract][Full Text] [Related]
23. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
[TBL] [Abstract][Full Text] [Related]
24. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling of childhood adrenocortical tumors.
West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
[TBL] [Abstract][Full Text] [Related]
26. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
27. Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.
Tatsi C; Stratakis CA
Clin Perinatol; 2018 Mar; 45(1):103-118. PubMed ID: 29406000
[TBL] [Abstract][Full Text] [Related]
28. KCNJ5 mutations are the most frequent genetic alteration in primary aldosteronism.
Williams TA; Monticone S; Mulatero P
Hypertension; 2015 Mar; 65(3):507-9. PubMed ID: 25624337
[No Abstract] [Full Text] [Related]
29. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61.
Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT
Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170
[TBL] [Abstract][Full Text] [Related]
30. Genetic aspects of adrenocortical tumours and hyperplasias.
Mazzuco TL; Durand J; Chapman A; Crespigio J; Bourdeau I
Clin Endocrinol (Oxf); 2012 Jul; 77(1):1-10. PubMed ID: 22471738
[TBL] [Abstract][Full Text] [Related]
31. Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse.
Bielinska M; Kiiveri S; Parviainen H; Mannisto S; Heikinheimo M; Wilson DB
Vet Pathol; 2006 Mar; 43(2):97-117. PubMed ID: 16537928
[TBL] [Abstract][Full Text] [Related]
32. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
[TBL] [Abstract][Full Text] [Related]
34. Estradiol-17 beta-secreting adrenocortical tumor in a ferret.
Lipman NS; Marini RP; Murphy JC; Zhibo Z; Fox JG
J Am Vet Med Assoc; 1993 Dec; 203(11):1552-5. PubMed ID: 8288478
[TBL] [Abstract][Full Text] [Related]
35. Medicine. The genetics of primary aldosteronism.
Funder JW
Science; 2011 Feb; 331(6018):685-6. PubMed ID: 21310991
[No Abstract] [Full Text] [Related]
36. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.
Libé R; Fratticci A; Coste J; Tissier F; Horvath A; Ragazzon B; Rene-Corail F; Groussin L; Bertagna X; Raffin-Sanson ML; Stratakis CA; Bertherat J
Clin Cancer Res; 2008 Jun; 14(12):4016-24. PubMed ID: 18559625
[TBL] [Abstract][Full Text] [Related]
37. Genetics of Cushing's syndrome.
Yaneva M; Vandeva S; Zacharieva S; Daly AF; Beckers A
Neuroendocrinology; 2010; 92 Suppl 1():6-10. PubMed ID: 20829611
[TBL] [Abstract][Full Text] [Related]
38. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
39. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
[TBL] [Abstract][Full Text] [Related]
40. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
